enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time ...

   www.aol.com/glp-1-drugs-no-longer-101500620.html

   Another GLP-1 drug, Trulicity, which is also used to treat type 2 diabetes, was its third-best-selling drug, but saw its sales fall 31% to $1.25 billion as patients shifted to its newer GLP-1 ...

3. Novo Nordisk 'comfortable' with impact of Medicare price ...

   www.aol.com/finance/novo-nordisk-comfortable...

   Novo Nordisk CEO Lars Jørgensen isn't too worried about the upcoming Medicare price negotiations over blockbuster GLP-1 drugs, even though the company still stands with the industry against the ...

4. Novo Nordisk CEO grilled by Senate committee over GLP-1 prices

   www.aol.com/finance/novo-nordisk-ceo-grilled...

   The drugs, known as GLP-1s, have brought in $50 billion in revenue for Novo Nordisk year to date alone, but the high prices ($1,349 for Wegovy and $968 for Ozempic) have put them out of reach for ...

5. Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is ...

   www.aol.com/finance/eli-lilly-shares-fall-glp...

   The good news for investors is that for 2025, overall guidance is looking strong. Lilly is projecting between $58 billion and $61 billion in sales, which is mostly higher than the $58.4 billion ...

6. Fighting words: Lilly and Novo swat back at the Biden ... - AOL

   www.aol.com/finance/fighting-words-lilly-novo...

   Click here for in-depth analysis of the latest health industry news and events impacting stock prices Read the latest financial and business news from Yahoo Finance Show comments

7. Novo Nordisk - Wikipedia

   en.wikipedia.org/wiki/Novo_Nordisk

   The Ozempic Lawsuits allege gastroparesis ileus and other injuries caused by GLP-1 RAS. The Case is known as MDL No. 3094 In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation. As of August 6, 2024 there were 235 active Ozempic lawsuits.

8. Amgen's peek at its GLP-1 drug trial results heightens ... - AOL

   www.aol.com/finance/amgens-peek-glp-1-drug...

   Amgen's positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday.CEO Bob Bradway shared a peek at phase II results of the ...

9. Global Partners - Wikipedia

   en.wikipedia.org/wiki/Global_Partners

   Global Partners LP (NYSE: GLP) is an American energy supply company ranked 361 in the 2018 Fortune 500. [3] The company is organized as a master limited partnership, and its operations focus on the importing of petroleum products and marketing them in North America. It wholesales products like crude oil, diesel oil, gasoline, heating oil and ...